Biosimilar drugs could create billions in health care savings, study finds
Introducing competing "biosimilar" versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade, ...
Nov 3, 2014
0
0